中文簡(jiǎn)介

由柳葉刀出版。國(guó)際標(biāo)準(zhǔn)書(shū)號(hào)：1470-2045?！读~刀腫瘤學(xué)》是一本月刊，評(píng)論期刊，在腫瘤學(xué)上發(fā)表文章、觀(guān)點(diǎn)、新聞和評(píng)論。歷史《柳葉刀腫瘤學(xué)》于2000年9月出版，是一本生動(dòng)、內(nèi)容豐富的月刊，涵蓋了與全球臨床癌癥專(zhuān)家相關(guān)的國(guó)際問(wèn)題。2005年5月，《華爾街日?qǐng)?bào)》擴(kuò)大了原有的研究范圍，并在印刷出版之前首先在網(wǎng)上發(fā)表文章。該雜志很快成為世界上最重要的原始研究出版物之一，特別是臨床試驗(yàn)報(bào)告，以及在倡導(dǎo)和全球衛(wèi)生領(lǐng)域。唯一的是，所有的原始研究都是通過(guò)一個(gè)快速的服務(wù)進(jìn)行同行評(píng)審的，成功的論文在提交后的8周內(nèi)發(fā)表。2008年，《華爾街日?qǐng)?bào)》將其在線(xiàn)業(yè)務(wù)擴(kuò)展到定期播客。柳葉刀腫瘤學(xué)也因主辦腫瘤學(xué)家、癌癥研究者和決策者的活動(dòng)而享有盛譽(yù)。2007年，柳葉刀腫瘤學(xué)在新加坡召開(kāi)了第一次會(huì)議，題為“21世紀(jì)的亞洲和癌癥管理”。另外，在2007，該雜志在舊金山、CA、美國(guó)的腫瘤學(xué)大會(huì)上主持了一個(gè)關(guān)于發(fā)展生物學(xué)、自我更新和癌癥的專(zhuān)題講座。隨后幾年，該雜志在2008年腫瘤大會(huì)和2009年亞洲腫瘤峰會(huì)上主持了第二次全體會(huì)議。2010年，柳葉刀腫瘤學(xué)“參與”會(huì)議的活動(dòng)進(jìn)一步擴(kuò)大，包括在印度尼西亞巴厘島舉行的第二次亞洲腫瘤學(xué)峰會(huì)，以及在荷蘭阿姆斯特丹舉行的關(guān)于人乳頭狀瘤病毒和癌癥的會(huì)議。自2011年以來(lái)，《柳葉刀》繼續(xù)主辦成功的亞洲腫瘤峰會(huì)，2015年，《柳葉刀》將在中國(guó)上海舉辦2015年4月10日至12日舉行的第七屆亞洲腫瘤峰會(huì)。計(jì)劃在2016年及以后舉辦更多活動(dòng)。該雜志還通過(guò)與特定組織和社會(huì)合作，參與癌癥健康保健的宣傳。聲譽(yù)和影響柳葉刀腫瘤學(xué)的影響因子為24.725。該期刊在全球202種腫瘤期刊中排名第三，是領(lǐng)先的臨床腫瘤研究期刊，在全球任何學(xué)科的所有科學(xué)期刊中排名前0.5%（2013年期刊引文報(bào)告，湯森路透2014年）。發(fā)表在《柳葉刀腫瘤學(xué)》上的文章定期在主流印刷媒體、在線(xiàn)媒體和廣播媒體上得到報(bào)道。新聞報(bào)道柳葉刀腫瘤學(xué)的目的是發(fā)表有趣的，信息豐富的，實(shí)踐變化的文章，任何與臨床腫瘤學(xué)相關(guān)的主題。主題包括但不限于：乳腺癌內(nèi)分泌系統(tǒng)癌胃腸道癌泌尿生殖癌婦科癌癥血液學(xué)癌癥頭頸癌神經(jīng)腫瘤學(xué)兒科腫瘤學(xué)胸腫瘤肉瘤皮膚癌流行病學(xué)、癌癥預(yù)防和癌癥控制支持性護(hù)理成像衛(wèi)生保健系統(tǒng)

投稿網(wǎng)址：http://ees.elsevier.com/thelancetoncology/

英文簡(jiǎn)介

PUBLISHED BY THE LANCET. ISSN: 1470-2045.THE LANCET ONCOLOGY IS A MONTHLY, REVIEW JOURNAL, WITH ARTICLES, VIEWPOINTS, NEWS AND REVIEWS IN ONCOLOGY.HISTORYTHE LANCET ONCOLOGY WAS LAUNCHED IN SEPTEMBER, 2000, AS A LIVELY AND INFORMATIVE MONTHLY JOURNAL COVERING INTERNATIONAL ISSUES RELEVANT TO CLINICAL CANCER SPECIALISTS WORLDWIDE. IN MAY, 2005, THE JOURNAL EXPANDED TO INCLUDE ORIGINAL RESEARCH AND BEGAN PUBLISHING ARTICLES ONLINE FIRST PRIOR TO PRINT PUBLICATION. THE JOURNAL QUICKLY ESTABLISHED ITSELF AS ONE OF THE PREMIER PUBLICATIONS WORLDWIDE FOR ORIGINAL RESEARCH, ESPECIALLY REPORTS FROM CLINICAL TRIALS, AND IN THE AREAS OF ADVOCACY AND GLOBAL HEALTH. UNIQUELY, ALL ORIGINAL RESEARCH IS PEER-REVIEWED VIA A FAST-TRACK SERVICE, AND SUCCESSFUL PAPERS ARE PUBLISHED WITHIN 8 WEEKS OF SUBMISSION. IN 2008, THE JOURNAL EXPANDED ITS ONLINE PRESENCE TO INCLUDE REGULAR PODCASTS.THE LANCET ONCOLOGY HAS ALSO DEVELOPED A REPUTATION FOR HOSTING EVENTS FOR ONCOLOGISTS, CANCER RESEARCHERS, AND POLICYMAKERS. IN 2007, THE LANCET ONCOLOGY CONVENED ITS FIRST CONFERENCE IN SINGAPORE ENTITLED ASIA AND CANCER MANAGEMENTIN THE 21ST CENTURY. ADDITIONALLY IN 2007, THE JOURNAL HOSTED A PLENARY LECTURE AT THE ONCOLOGY CONGRESS IN SAN FRANCISCO, CA, USA, ON THE TOPIC OF DEVELOPMENTAL BIOLOGY, SELF RENEWAL, AND CANCER. IN SUBSEQUENT YEARS, THE JOURNAL HOSTED A SECOND PLENARY LECTURE AT THE 2008 ONCOLOGY CONGRESS, AND THE INAUGURAL ASIAN ONCOLOGY SUMMIT IN 2009. IN 2010, THE LANCET ONCOLOGY''''''''S INVOLVEMENT IN CONFERENCES EXPANDED WITH FURTHER EVENTS, INCLUDING A SECOND ASIAN ONCOLOGY SUMMIT IN BALI, INDONESIA, AND A CONFERENCE ON HPV AND CANCER IN AMSTERDAM, THE NETHERLANDS. SINCE 2011, THE JOURNAL HAS CONTINUED TO HOST THE SUCCESSFUL ASIAN ONCOLOGY SUMMITS AND IN 2015, THE LANCET ONCOLOGY WILL HOST THE 7TH ASIAN ONCOLOGY SUMMIT TO TAKE PLACE APRIL 10-12, 2015 IN SHANGHAI, CHINA. FURTHER EVENTS ARE PLANNED FOR 2016 AND BEYOND. THE JOURNAL IS ALSO INVOLVED IN CANCER HEALTH-CARE ADVOCACY BY PARTNERING WITH SPECIFIC ORGANISATIONS AND SOCIETIES.REPUTATION AND IMPACTTHE LANCET ONCOLOGY HAS AN IMPACT FACTOR OF 24·725. THE JOURNAL RANKS THIRD OUT OF 202 ONCOLOGY JOURNALS WORLDWIDE, IS THE LEADING CLINICAL ONCOLOGY RESEARCH JOURNAL, AND IS IN THE TOP 0·5% OF ALL SCIENTIFIC JOURNALS, OF ANY DISCIPLINE, GLOBALLY (2013 JOURNAL CITATION REPORTS?, THOMSON REUTERS 2014). ARTICLES PUBLISHED IN THE LANCET ONCOLOGY REGULARLY RECEIVE COVERAGE IN THE MAINSTREAM PRINT, ONLINE, AND BROADCAST MEDIA.COVERAGETHE AIM OF THE LANCET ONCOLOGY IS TO PUBLISH INTERESTING, INFORMATIVE, AND PRACTICE-CHANGING ARTICLES ON ANY TOPIC CONNECTED WITH CLINICAL ONCOLOGY. TOPICS INCLUDE, BUT ARE NOT LIMITED TO: BREAST CANCER ENDOCRINE SYSTEM CANCER GASTROINTESTINAL CANCER GENITOURINARY CANCER GYNAECOLOGICAL CANCER HAEMATOLOGICAL CANCER HEAD AND NECK CANCER NEUROONCOLOGY PAEDIATRIC ONCOLOGY THORACIC ONCOLOGY SARCOMA SKIN CANCER EPIDEMIOLOGY, CANCER PREVENTION, AND CANCER CONTROL SUPPORTIVE CARE IMAGING HEALTH-CARE SYSTEMS